IMMC - Industry leading Diabetes Drug Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMC - Industry leading Diabetes Drug

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David in Ontario who wrote (17)	3/22/1999 11:56:00 AM
From: Rich Kaiser	of 55

Hi Dave, Always good to see you on a thread. Management appears very confident about the near term performance for the Company. The single biggest reason why the stock came off from its Dec. high was the financial problems in Brazil. Remember: Immunis get 25% of all sales of the DAIB-II drug anywhere outside of China. Currently, the Company will show the efforts of Biotech arrangements in S. America. To say the least, investors who got spooked because they didn't understand simple Health Economics(meaning there is no direct correlation between someone who is sick and that of the macroeconomic situation as a whole left good value stock on the table for the value seeking investors. So, if you are sick and the economy around you continue to shrink you are still going to get medical attention. Rich

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next